We are live on ! Find out more
BKYI

BIO-key International

14 hedge funds and large institutions have $1.28M invested in BIO-key International in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

17% more funds holding

Funds holding: 1214 (+2)

0% less ownership

Funds ownership: 0.04%0.04% (-0%)

38% less capital invested

Capital invested by funds: $2.06M → $1.28M (-$777K)

73% less call options, than puts

Call options by funds: $323K | Put options by funds: $1.18M

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
2
Closed
3
Calls
$323K
Puts
$1.18M
Net Calls
-$853K
Net Calls Change
+$130K

BKYI Hedge Fund Activity: Q4 2021 in Review

14 institutional investors reported a position in BIO-key International (BKYI) for Q4 2021, worth a combined $1.28M — down 38% from $2.06M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BKYI positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $63.1K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $209K sold.

  • 14 institutional investors held BIO-key International (BKYI) as of Q4 2021, up from 12 in Q3 2021.
  • Funds reported $1.28M of BIO-key International stock for Q4 2021, down 38% quarter-over-quarter.
  • 5 funds opened new BIO-key International positions in Q4 2021 and 3 closed out, a net change of +2 holders.
  • The largest BIO-key International buyer in Q4 2021 was Citadel Advisors, an estimated $63.1K added.
  • The largest BIO-key International seller in Q4 2021 was Two Sigma Investments, an estimated $209K sold.

Based on aggregated 13F filings for Q4 2021.